Press Releases

Cell-Based Solutions for Tumor Research Are Available by Creative Proteomics’s Tumomics Platform

Creative Proteomics Introduces Advanced Gut Metatranscriptome Analysis Solutions

Creative Enzymes Optimizes Screening of Enzyme Activators for Enzyme Profiling

IM Therapeutics Expands Management Team with Appointments of Tom Shea as CFO/COO and Dr. Sarah Bird as VP, Clinical Development

Creative Enzymes Optimizes Enzyme Stabilization and Formulation Services

Alfa Chemistry Testing Lab Provides Customized Pharmaceutical Analytical Services

Alfa Chemistry Testing Lab announced today that it has recently launched customized pharmaceutical analytical services for companies involved with new drug development.

CD Genomics Announces MicroCollect™ FDA&CE Certificated Virus Collection Swab Kits for SARS-CoV-2 Detection

FHI CLINICAL INC. PROVIDING CLINICAL OPERATIONS SERVICES FOR ACTT-1 TRIAL OF REMDESIVIR FOR TREATMENT OF COVID-19

FHI Clinical announced today a subcontract with the Frederick National Laboratory for Cancer Research, currently operated by Leidos Biomedical Research, Inc., to provide clinical operations services for the Adaptive COVID-19 Treatment Trial (ACTT). Supported by the NIAID, part of the NIH, the ongoing ACTT study is a randomized, double-blinded, placebo-controlled trial to allow investigation of putative therapeutics for the treatment of COVID-19 in hospitalized adults.

Elligo Launches Expanded System of Accelerated Research (SOAR™)

Elligo Health Research®, a healthcare-enabling research organization, is launching their fully realized System of Accelerated Research (SOAR) model for decentralized (DCTs) and hybrid trial models with fully remote monitoring capabilities.

Elucid Digital Health’s dashboard gives pharma and CROs real time patient adherence data during a clinical trial

Elucid’s Pill Connect dispensing system provides CROs and pharma the ability to show adherence across the whole trial, by country, by site even down to the individual patient number in real time.

Profacgen Updated Its CLIP-Seq Service for RNA-Protein Interaction Study

Creative Biostructure Released Cryo-EM for Gene Therapy

Creative BioMart Updated Its Bacterial Expression Systems for Protein Expression Service

Creative Bioarray Release Validated Preclinical Models to Support All Stages of Drug Discovery

Research Presentation Strategies Announces New System Enabling the First-Ever Full Day Virtual FDA Drug Approval AdComm Presentation

Research Presentation Strategies (RPS), the leader in FDA advisory committee (AdComm) presentation support, announced the use of their technology platform for a successful virtual Cardio-Renal Drug Advisory Committee (CRDAC) meeting that took place on July 15, 2020. The RPS platform was utilized by a sponsor last week for the first fully virtual, day-long drug approval AdComm presentation.

Matexcel Enlarged Its Chitosan Products Offerings

Lifeasible Supports a Comprehensive Range of Environmental Tests

Creative Diagnostics Expands Response to COVID-19 to Recombinant SARS-CoV-2 RBD Mutants

The global cases of COVID-19 are expected to soar unceasingly, and to facilitate related research worldwide, Creative Diagnostics integrates recombinant SARS-CoV-2 RBD mutants to its SARS-CoV-2 products and services.

CsPbX3 Perovskite Nanocrystals Are Now Available at Creative Diagnostics

Quantum dots have long been a focus of researches on photovoltaic devices, biosensors and catalysis and as a global supplier with experienced technical teams, Creative Diagnostics introduces CsPbX3 Perovskite Nanocrystals for various applications.

CD Bioparticles: A Trustworthy Provider of All Sorts of PEG Conjugations

As a top-class institution as well as experienced supplier in drug delivery, CD Bioparticles now launches cover-all PEG conjugations to global clients.